AJP - Heart Journal of Neurophysiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 274: H1174-H1183, 1998;
0363-6135/98 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Duffy, S. J.
Right arrow Articles by Meredith, I. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Duffy, S. J.
Right arrow Articles by Meredith, I. T.
Vol. 274, Issue 4, H1174-H1183, April 1998

Continuous release of vasodilator prostanoids contributes to regulation of resting forearm blood flow in humans

Stephen J. Duffy1, Binh T. Tran1, Gishel New1, Ronald N. Tudball1, Murray D. Esler2, Richard W. Harper1, and Ian T. Meredith1

1 Cardiovascular Centre, Cardiology Unit, Monash University Department of Medicine, Monash Medical Centre, and 2 Baker Medical Research Institute, Melbourne, Victoria 3168, Australia

Continuous release of nitric oxide contributes to the maintenance of resting tone in the human forearm and coronary circulations; however, evidence for a similar role of vasodilator prostanoids such as prostacyclin is lacking. We examined whether continuous release of prostacyclin contributes to basal forearm blood flow. Flow was measured using venous occlusion plethysmography in 38 healthy volunteers [mean age 21.3 ± 2.5 yr (±SD); 13 female, 25 male] at rest, after administration of three incremental intra-arterial infusions of either the cyclooxygenase inhibitor aspirin or placebo, and before and after administration of the endothelium-dependent and -independent dilators acetylcholine (30 µg/min) and nitroprusside (1 µg/min). To assess the effect of aspirin on the production of prostacyclin, plasma 6-keto prostaglandin F1alpha (6-keto-PGF1alpha ; the stable metabolite of prostacyclin) was measured by simultaneous arterial and venous sampling. Aspirin produced a time- and dose-dependent reduction in forearm blood flow, resulting in a 32% decrease at the highest dose. The effect was maximal after 10 min. Flow at rest and after aspirin doses of 1, 3, and 10 mg/min was 2.6 ± 0.2, 2.3 ± 0.2, 2.1 ± 0.2, and 1.8 ± 0.2 ml · 100 ml forearm tissue-1 · min-1, respectively (means ± SE, P < 0.001). Commensurate with these data, the net forearm production of 6-keto-PGF1alpha was 52.9 ± 16.4, 11.7 ± 8.6, 18.7 ± 8.5, and 12.0 ± 12.5 pg · 100 ml forearm tissue-1 · min-1 for the respective doses (P = 0.04). No time-dependent reduction in flow was seen in subjects with vehicle infusion. Aspirin did not affect the responses to acetylcholine or nitroprusside. These data suggest that continuous release of prostacyclin plays a role in the maintenance of resting forearm blood flow. There appears to be a direct link between the reduction in flow with aspirin and inhibition of prostacyclin production.

aspirin; eicosanoids; vasodilation; vasoconstriction; regional blood flow


This article has been cited by other articles:


Home page
 Journal of Renin-Angiotensin-Aldosterone SystemHome page
G. J Dietze and E. J Henriksen
Review: Angiotensin-converting enzyme in skeletal muscle: sentinel of blood pressure control and glucose homeostasis
Journal of Renin-Angiotensin-Aldosterone System, June 1, 2008; 9(2): 75 - 88.
[Abstract] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. D. Bradford, J. D. Cotter, M. S. Thorburn, R. J. Walker, and D. F. Gerrard
Exercise can be pyrogenic in humans
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R143 - R149.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
F. A. Dinenno and M. J. Joyner
Combined NO and PG inhibition augments {alpha}-adrenergic vasoconstriction in contracting human skeletal muscle
Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2576 - H2584.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
H. M. O. Farouque and I. T. Meredith
Relative contribution of vasodilator prostanoids, NO, and KATP channels to human forearm metabolic vasodilation
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2405 - H2411.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
R. K. Kharbanda, B. Walton, M. Allen, N. Klein, A. D. Hingorani, R. J. MacAllister, and P. Vallance
Prevention of Inflammation-Induced Endothelial Dysfunction: A Novel Vasculo-Protective Action of Aspirin
Circulation, June 4, 2002; 105(22): 2600 - 2604.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
M. Berghoff, M. Kathpal, S. Kilo, M. J. Hilz, and R. Freeman
Vascular and neural mechanisms of ACh-mediated vasodilation in the forearm cutaneous microcirculation
J Appl Physiol, February 1, 2002; 92(2): 780 - 788.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
S. Verma, S. R. Raj, L. Shewchuk, K. J. Mather, and T. J. Anderson
Cyclooxygenase-2 Blockade Does Not Impair Endothelial Vasodilator Function in Healthy Volunteers: Randomized Evaluation of Rofecoxib Versus Naproxen on Endothelium-Dependent Vasodilatation
Circulation, December 11, 2001; 104(24): 2879 - 2882.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
S. J. Duffy, S. F. Castle, R. W. Harper, and I. T. Meredith
Contribution of Vasodilator Prostanoids and Nitric Oxide to Resting Flow, Metabolic Vasodilation, and Flow-Mediated Dilation in Human Coronary Circulation
Circulation, November 9, 1999; 100(19): 1951 - 1957.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
S. J. Duffy, G. New, B. T. Tran, R. W. Harper, and I. T. Meredith
Relative contribution of vasodilator prostanoids and NO to metabolic vasodilation in the human forearm
Am J Physiol Heart Circ Physiol, February 1, 1999; 276(2): H663 - H670.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online